Protocol for a phase 3, active (warfarin) controlled, randomized, double-blind, parallel-arm study to evaluate efficacy and safety of apixaban in preventing stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Öffnen
Autor
Παγκαλίδου, ΕιρήνηSupervisor name
Στεφανίδης, Ιωάννης Λ.
Datum
2015Language
en
Schlagwort
Access
free
Academic publisher
Πανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής.
